info@businessghana.com
Pharmanova Limited, a proud Ghanaian pharmaceutical company founded on May 5 2005, by its visionary founder Dhananjay Tripathi, has been providing high-quality, affordable healthcare solutions to Ghanaians for nearly two decades.
In 2017, the company made a bold move towards industrial transformation by adopting an import-substitution strategy under the banner “Made in Ghana.”
This action aimed to strengthen local manufacturing capacity and generate jobs, while reducing dependence on imported medicines.
Pharmanova shifted from importing critical sterile products — including infusions, eye/ear/nasal drops, and inhalation anaesthetics — to manufacturing them locally.
This vision led to the establishment of Atlantic Lifesciences Ltd., a state-of-the-art sterile pharmaceutical manufacturing facility at Larkpleku, within the Ningo-Prampram District of the Greater Accra Region.
With strategic financial backing from EXIMBANK Ghana and Standard Chartered Bank, Atlantic Lifesciences was established in 2017 and has since developed into a national asset within Ghana’s pharmaceutical manufacturing sector.
Today, Atlantic Lifesciences is manufacturing a wide range of sterile products using advanced European technology and machinery, and is making strategic investments to expand into vaccine production.
In a major milestone for Ghana’s pharmaceutical industry, Atlantic Lifesciences has finalised various technology transfer agreements for the local fill and finish production of vaccines.
This achievement positions Ghana as an emerging hub for vaccine manufacturing in the West African sub-region.
Atlantic Lifesciences has attained Ghana’s first-ever Marketing Authorisation Holder (MAH) status for a locally manufactured biological product, Snake Venom Anti Serum — marking a historic milestone in the country's pharmaceutical capabilities.
In August 2025, Atlantic Lifesciences will begin the first-ever local fill and finish production of the tetanus diphtheria vaccine in Ghana, in collaboration with its technology partner, PT Biofarma of Indonesia. This partnership signifies a shared commitment towards vaccine equity, public health resilience and regional self-sufficiency.
The progress of Pharmanova and Atlantic Lifesciences reflects the deepening economic and technological partnership between India and Ghana.
The visit of the Prime Minister of India, Narendra Modi, to Ghana underscores the importance of this bilateral relationship and the success stories in the pharmaceutical sector.
The Indian diaspora and Indian-led enterprises such as Pharmanova have become integral to Ghana’s development journey — creating jobs, transferring technology and building local capacity in critical sectors such as health.
As Ghana charts a path toward pharmaceutical and vaccine sovereignty, the collaboration between Indian and Ghanaian institutions serves as a model for South-South cooperation rooted in mutual respect, shared growth and innovation.
